Related Experiment Video
Updated: Jun 17, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Rheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL
Dongzhu Ma1, Xiaochun Bai, Huafei Zou
1Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
FKBP38 is a member of the family of FK506-binding proteins that acts as an inhibitor of the mammalian target of rapamycin (mTOR). The inhibitory action of FKBP38 is antagonized by Rheb, an oncogenic small GTPase, which interacts with FKBP38 and prevents its association with mTOR. In addition to the role in mTOR regulation, FKBP38 is also involved in binding and recruiting Bcl-2 and Bcl-X(L), two anti-apoptotic proteins, to mitochondria. In this study, we investigated the possibility that Rheb controls apoptosis by regulating the interaction of FKBP38 with Bcl-2 and Bcl-X(L). We demonstrate in vitro that the interaction of FKBP38 with Bcl-2 is regulated by Rheb in a GTP-dependent manner. In cultured cells, the interaction is controlled by Rheb in response to changes in amino acid and growth factor conditions. Importantly, we found that the Rheb-dependent release of Bcl-X(L) from FKBP38 facilitates the association of this anti-apoptotic protein with the pro-apoptotic protein Bak. Consequently, when Rheb activity increases, cells become more resistant to apoptotic inducers. Our findings reveal a novel mechanism through which growth factors and amino acids control apoptosis.
Insights
The oncogenic Rheb protein regulates apoptosis by controlling FKBP38
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- FKBP38 inhibits the mammalian target of rapamycin (mTOR).
- Rheb, an oncogenic GTPase, antagonizes FKBP38's mTOR inhibition.
- FKBP38 binds anti-apoptotic proteins Bcl-2 and Bcl-X(L), recruiting them to mitochondria.
Purpose of the Study:
- To investigate if Rheb controls apoptosis by modulating FKBP38 interactions with Bcl-2 and Bcl-X(L).
Main Methods:
- In vitro binding assays to assess Rheb-dependent FKBP38-Bcl-2 interactions.
- Cell culture experiments to observe Rheb's control over FKBP38 interactions under varying nutrient and growth factor conditions.
- Analysis of the association between Bcl-X(L) and Bak in response to Rheb activity.
Main Results:
- Rheb regulates the interaction between FKBP38 and Bcl-2 in a GTP-dependent manner in vitro.
- Rheb controls FKBP38 interactions with Bcl-2 in response to amino acid and growth factor availability in cultured cells.
- Rheb-dependent release of Bcl-X(L) from FKBP38 promotes Bcl-X(L) association with the pro-apoptotic protein Bak.
Conclusions:
- Rheb modulates apoptosis by regulating the interaction of FKBP38 with anti-apoptotic proteins Bcl-2 and Bcl-X(L).
- Increased Rheb activity enhances cellular resistance to apoptosis.
- This study reveals a novel pathway for growth factor and amino acid control of apoptosis via Rheb-FKBP38-Bcl-xL signaling.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway

